Through his work on the podcast "Futures in Biotech," scientist Marc Pelletier has access to some of the field's top minds. He's using that access to shape his own thinking as early stage startup, Aeromics, looks to develop a drug to reduce swelling in the brain.
Cleveland is already well-known for its high quality medical care. But its reputation is growing elsewhere. Some of the nation’s best and brightest are flocking to University Circle to be on the cutting edge of the biotech innovation. Channel 3’s Maureen Kyle continues our “Brain Gain” series with a look at how this could be […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The company will use the grant to further its development of a drug that reduces brain swelling in stroke victims.